Posted by Michael Wonder on 16 May 2017
New guidance for patient group partners taking part in SMC Committee meetings
15 May 2017 - From June 2017, the SMC will be introducing new processes to improve how they involve patient groups in their committee meetings.
The new processes, which will see patient groups actively involved in the relevant parts of our committee meetings, aim to enhance the quality of discussion and decision making. The changes follow on from the publication of the review into access to new medicines in December 2016.
The new processes will initially be introduced for medicines being considered through the Patient and Clinician Engagement (PACE) process, for medicines used to treat end of life and very rare conditions. Following a trial period, the new process will be rolled out to cover all medicines in autumn 2017.
